Taisho licenses Moberg’s MOB-015 in Japan

4 October 2019 - Deborah Wilkes

Taisho Pharmaceutical has signed an exclusive Japanese licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.